MediPharm Labs Corp. (TSE:LABS – Get Free Report)’s share price hit a new 52-week high during mid-day trading on Monday . The company traded as high as C$0.10 and last traded at C$0.09, with a volume of 745630 shares traded. The stock had previously closed at C$0.09.
MediPharm Labs Stock Performance
The firm’s 50 day moving average is C$0.07 and its 200 day moving average is C$0.07. The company has a debt-to-equity ratio of 1.45, a quick ratio of 3.10 and a current ratio of 3.21. The stock has a market cap of C$37.35 million, a P/E ratio of -3.10 and a beta of 0.88.
MediPharm Labs Company Profile
MediPharm Labs Corp., a pharmaceutical company, produces and sells pharmaceutical-quality cannabis oil and concentrates, and advanced derivative products in Canada and internationally. The company formulates, processes, packages, and distributes cannabis extracts and advanced cannabinoid-based products.
See Also
- Five stocks we like better than MediPharm Labs
- What is the MACD Indicator and How to Use it in Your Trading
- 3 Cash Cow Stocks Leading Their Sectors in Free Cash Flow Margins
- How to Use High Beta Stocks to Maximize Your Investing Profits
- Retail Sales Data Signals a Surge: The E-Commerce Stock Picks
- The How And Why of Investing in Oil Stocks
- Qualcomm’s Low PE Ratio Makes It A Seriously Attractive Stock
Receive News & Ratings for MediPharm Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MediPharm Labs and related companies with MarketBeat.com's FREE daily email newsletter.
